Senior Director Global Head Portfolio Management CM&E, N&I, Fertility

<p> </p> <p>Work Your Magic with us!  </p> <p> </p> <p>Ready to explore, break barriers, and discover more? We know you’ve got big plans – so do we! Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Healthcare, Life Science, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and planet. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us.</p> <p> </p> <p>United As One for Patients, our purpose in Healthcare is to help create, improve and prolong lives. We develop medicines, intelligent devices and innovative technologies in therapeutic areas such as Oncology, Neurology and Fertility. Our teams work together across 6 continents with passion and relentless curiosity in order to help patients at every stage of life. Joining our Healthcare team is becoming part of a diverse, inclusive and flexible working culture, presenting great opportunities for personal development and career advancement across the globe.</p> <p> </p> <p>Senior Director, Global Head of Portfolio Management CM&amp;E, N&amp;I, Fertility</p> <p> </p> <p>THE ROLE:</p> <p> </p> <p>This role is responsible for all aspects of the N&amp;I, CM&amp;E, and Fertility projects portfolio. There are a substantial number of ongoing projects within the portfolio, some 35 likely to come under the jurisdiction of this position at various stages of the life cycle, representing significant investments and/or value creation.</p> <p> </p> <p>The nature of this role requires the successful candidate to be able to work effectively across a highly matrixed organisation (from Research to Development to Commercial). While they will have direct reports in the day-to-day working environment, this role is all about exerting influence without direct responsibility.</p> <p> </p> <p>This role is, for the most part, internally facing, having key interactions with senior Research, Development and Commercial Leaders, in Global, Regional and Local organisations, and so requires this person to display significant emotional intelligence, in order to understand the different drivers and priorities that may exist.</p> <p> </p> <p>However, this person will also need to understand the wider external competitive environment for all current and future assets at whichever stage of their lifecycle they currently sit. They must also be able to advise on business development, licensing and acquisition strategy for potential externally derived asset value creation.</p> <p> </p> <p>To be successful in this role the new incumbent will need to provide a balanced opinion on all aspects of programs and the overall portfolio and the current and future value each can bring to the organisation. They will essentially be the provider of facts that will facilitate key decision making, particularly on future investments within the portfolio as well as to enable go/no go decisions across the lifecycle.</p> <p> </p> <p>This person will advise (but not own) on the following portfolio investments. </p> <p> </p> <ul> <li>The pre-POC assets owned by Development.</li> <li>The post-POC assets owned by Development.</li> <li>New Business Units, for example the BioElectronics unit.</li> <li>LCM assets projects owned by GBFs,</li> <li>Major-region-specific (US; Japan; China etc.) sub-sets of the above portfolio assets.</li> <li>Licensing (both commercial and global), portfolio divestiture and acquisition </li> </ul> <p> </p> <p> </p> <p>As such key internal interfaces across the organisation will be:</p> <p> </p> <ul> <li>Healthcare Executive Committee (HEC) Members</li> <li>Divisional and Group Strategy</li> <li>Finance Controlling</li> <li>Investor Relation</li> <li>Global Business Franchise Leadership Teams</li> <li>Global Business Development</li> <li>Research, and Development Management Teams</li> <li>GHO</li> <li>Internal expert advisory groups (e.g. External Scientific Affairs)</li> </ul> <p> </p> <p>Key external interfaces will be:</p> <p> </p> <ul> <li>Pharmaceutical industry portfolio management community</li> <li>Best practice and benchmarking pharma and innovation-driven non-pharma industry organizations</li> <li>External experts and consultants</li> </ul> <p> </p> <p> </p> <p>More detailed responsibilities include:</p> <p> </p> <ul> <li>Coordinating content and timing guidance for Divisional Portfolio Revue and Divisional level SD</li> <li>Maintaining and refining the divisional-wide tools, templates and processes employed for asset-level analysis</li> <li>Ensuring inter-divisional and industry best-practice sharing</li> <li>Introducing, coordinating and refining tailored project-level evaluation training programs throughout the Division</li> <li>Orchestrating Cross-Divisional Portfolio Calibrations for Divisional Portfolio Revue and SD HEC &amp; GL submissions</li> <li>Tracking year-on-year Divisional portf